| Literature DB >> 8150781 |
Abstract
This article examines questions about adjuvant systemic therapy, especially in premenopausal and postmenopausal women. The impact of adjuvant therapy on quality of life is addressed, as is the role of doxorubicin in adjuvant chemotherapy. The value of high dose adjuvant chemotherapy and late effects of adjuvant therapy are also examined.Entities:
Mesh：
Substances：
Year: 1994 PMID： 8150781
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN： 0889-8588 Impact factor: 3.722